MedPath

LABORATORIOS CASEN-FLEET S.L.U

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

2 Phases

Phase 3:1
Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 3
1 (50.0%)
Phase 4
1 (50.0%)

Clinical Trial to Evaluate the Efficacy of FITOGYN Versus Placebo on the Vasomotor Symptomatology Associated With Menopause

Phase 4
Conditions
Postmenopausal Women With Moderate Vasomotor Symptoms
Interventions
Drug: Soy isoflavones (Glycine max L) and red clover extract (Trifolium pretense L)
Drug: Placebo
First Posted Date
2010-05-04
Last Posted Date
2011-09-28
Lead Sponsor
Laboratorios Casen-Fleet S.L.U.
Target Recruit Count
166
Registration Number
NCT01116310
Locations
🇪🇸

Hospital Central de Asturias, Asturias, Spain

🇪🇸

Hospital del Cruces, Barakaldo, Spain

🇪🇸

Assir CAP Sant Martí, Barcelona, Spain

and more 17 locations

Safety and Efficacy Study of CitraFleet (Sodium Picosulphate) as an Evacuating Treatment Prior to Colonoscopy.

Phase 3
Completed
Conditions
Subjects Undergoing a Complete Exploratory Diagnostic Colonoscopy for the First Time.
Interventions
Drug: Sodium picosulphate, light magnesium oxide and anhydride citric acid.
Drug: Polyethylene glycol, KCl, NaCl, sodium sulphate anhydrous and sodium bicarbonate.
First Posted Date
2010-02-09
Last Posted Date
2011-04-15
Lead Sponsor
Laboratorios Casen-Fleet S.L.U.
Target Recruit Count
547
Registration Number
NCT01065857
Locations
🇪🇸

H. Infanta Elena, Valdemoro, Madrid, Spain

🇪🇸

Clínica Universitaria de Navarra, Pamplona, Navarra, Spain

🇪🇸

H. Universitario de Canarias, La Laguna, Tenerife, Spain

and more 12 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.